JANUMET XR 50 mg/1

Janumet XR 50 mg/1 combines sitagliptin and metformin hydrochloride in extended-release tablets for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Janumet XR 50 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. It works by enhancing insulin sensitivity and reducing glucose production in the liver. This medication is often prescribed alongside diet and exercise to manage blood sugar levels effectively.

Common effects of Janumet XR 50 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when starting treatment. Some users may also experience headache or dizziness. These effects are generally mild and temporary as the body adjusts to the medication.

Janumet XR 50 mg/1 should be handled with care, especially for individuals with kidney or liver issues. It is important to follow the prescribed dosage and monitor blood sugar levels regularly. Avoid alcohol consumption while taking this medication, as it may increase the risk of side effects.

Janumet XR 50 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.